Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAS 102”

112 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 112 results

Testing effectiveness (Phase 2)Study completedNCT03686488
What this trial is testing

TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaGastric Cancer
H. Lee Moffitt Cancer Center and Research Institute 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07196345
What this trial is testing

TAS-102 Plus Radiotherapy in Elderly ESCC

Who this might be right for
ESCCTAS 102Radiotherapy
Qianfoshan Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT06242067
What this trial is testing

Second-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Hospital of Shandong University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05927857
What this trial is testing

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Who this might be right for
Metastatic Gastric AdenocarcinomaSecond LineChemotherapy
National Health Research Institutes, Taiwan 45
Early research (Phase 1)Study completedNCT01916447
What this trial is testing

A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.

Who this might be right for
Advanced Gastrointestinal Tumors
Taiho Oncology, Inc. 65
Testing effectiveness (Phase 2)Study completedNCT03981614
What this trial is testing

Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer

Who this might be right for
Metastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+3 more
Academic and Community Cancer Research United 102
Testing effectiveness (Phase 2)UnknownNCT03762161
What this trial is testing

A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer

Who this might be right for
Bladder Cancer
Rahul Parikh 22
Testing effectiveness (Phase 2)UnknownNCT05266820
What this trial is testing

Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fujian Cancer Hospital 120
Early research (Phase 1)Ended earlyNCT02943733
What this trial is testing

Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs

Who this might be right for
Neuroendocrine TumorsNeoplasmsCancer+1 more
University of Wisconsin, Madison 18
Testing effectiveness (Phase 2)Study completedNCT04097028
What this trial is testing

Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8+13 more
Roswell Park Cancer Institute 22
Not applicableLooking for participantsNCT06102785
What this trial is testing

Fruquintinib Combined With TAS102 for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Study completedNCT02031055
What this trial is testing

Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 8
Early research (Phase 1)Study completedNCT03317119
What this trial is testing

Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colon CarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Carcinoma+22 more
City of Hope Medical Center 26
Early research (Phase 1)Study completedNCT01867866
What this trial is testing

Study Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD Alone

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 44
Testing effectiveness (Phase 2)Looking for participantsNCT06711471
What this trial is testing

Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer

Who this might be right for
Gastric Cancer Adenocarcinoma Metastatic
LIN YANG 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05364489
What this trial is testing

Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
The First Affiliated Hospital of Zhengzhou University 20
Not applicableStudy completedNCT05839951
What this trial is testing

An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Bayer 818
Testing effectiveness (Phase 2)Ended earlyNCT02921737
What this trial is testing

TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)

Who this might be right for
Pancreatic Cancer
University of Florida 7
Testing effectiveness (Phase 2)Study completedNCT03278106
What this trial is testing

TAS-102 in Treating Advanced Biliary Tract Cancers

Who this might be right for
CholangiocarcinomaStage III Gallbladder Cancer AJCC v7Stage IIIA Gallbladder Cancer AJCC v7+4 more
Mayo Clinic 28
Testing effectiveness (Phase 2)UnknownNCT04660760
What this trial is testing

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+28 more
Academic and Community Cancer Research United 116
Load More Results